Favorable effect of cytomegalovirus reactivation on outcomes in cord blood transplantation and its differences among disease risk or types.Biol Blood Marrow Transplant.(2020).
Conditioning intensity for allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with poor-prognosis cytogenetics in first complete remission.Biol Blood Marrow Transplant.(2019).
Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.Acta Haematol141, 111-118.(2019).
The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy.Int J Infect Dis.(2019).
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-host disease by National Institutes of Health Criteria in a Japanese cohort.Biol Blood Marrow Transplant.(2019).
Report of phase I and II trials of melphalan, prednisolone, and thalidomide triplet combination therapy versus melphalan and prednisolone doublet combination therapy in Japanese patients with newly diagnosed multiple myeloma ineligible for autologous stem.Int J Hematol.(2019).
Central nervous system infection following allogeneic hematopoietic stem cell transplantation.Hematol Oncol Stem Cell Ther.(2016).
CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplantation predicts relapse in patients with acute myeloid leukemia without complete remission.Leuk Lymphoma1-14.(2015).